Compare

BPC-157 vs Ipamorelin

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

BPC-157

126 community reports

Positive 98% · Neutral 2% · Negative 0%

Most reported benefits

Recovery
245

Most reported side effects

Nausea
5

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
2
25–50
1
50–100
0
100–200
3
200–400
138
400–600
93
600–1000
5
1000–2000
1
2000+
2

How repeat users are trending

Among repeat reporters, 94% said they felt similar to their last entry, 6% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 50 days · Based on 47 repeat reporters

Ipamorelin

102 community reports

Positive 98% · Neutral 2% · Negative 0%

Most reported benefits

Energy
236
Sleep
236

Most reported side effects

Water retention
2
Headache
2

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
12
100–200
63
200–400
137
400–600
22
600–1000
0
1000–2000
0
2000+
2

How repeat users are trending

Among repeat reporters, 98% said they felt similar to their last entry, 2% more positive, and 0% more negative.

Overall, repeat reporters leaned similar or mixed compared to their previous entry.

Median gap between entries: 51 days · Based on 44 repeat reporters